Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
LaFleur Expands Swanson Gold Deposit System, Confirming Strong Continuity with 2.95 g/t Au over 80.00 metres and 2.37 g/t Au over 88.05 metres
Yukon Metals Just Optioned a Sumitomo-Drilled Copper-Gold Project Next to Its Birch Discovery - Here's What's Now in Play in the Yukon
Homerun Resources Inc. Announces Positive Bankable Feasibility Study on Solar Glass Manufacturing Plant in Brazil, Confirming Strong Economics and Strategic First-Mover Position in the Americas
